Urology therapeutics Market Research Reports
Title | published | price | |
---|---|---|---|
Inherited Mitochondrial Disorders (Genetic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... report provides comprehensive information on the therapeutics under development for Inherited Mitochondrial Disorders, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule ......" | 30-Apr-2021 | $2000 | |
X-Linked SCID (Genetic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... s under development for X-Linked SCID, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the thera......" | 30-Apr-2021 | $2000 | |
Renal Failure (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021By Global Markets Direct "...... mprehensive information on the therapeutics under development for Renal Failure, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descr......" | 30-Apr-2021 | $2000 | |
Gaucher Disease Type III (Genetic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... ve information on the therapeutics under development for Gaucher Disease Type III, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the des......" | 30-Apr-2021 | $2000 | |
GM1 Gangliosidosis (Beta Galactosidase 1 Deficiency) (Genetic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... idase 1 Deficiency) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for GM1 Gangliosidosis (Beta Galactosidase 1 Deficiency), complete with analysis by Stage of Development, Drug Ta......" | 30-Apr-2021 | $2000 | |
Subacute Necrotizing Encephalomyelopathy (Leigh Disease) (Genetic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... phalomyelopathy (Leigh Disease) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Subacute Necrotizing Encephalomyelopathy (Leigh Disease), complete with analysis by Stage of Deve......" | 30-Apr-2021 | $2000 | |
Stress Urinary Incontinence (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021By Global Markets Direct "...... scape.
The report provides comprehensive information on the therapeutics under development for Stress Urinary Incontinence, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (......" | 30-Apr-2021 | $2000 | |
Achromatopsia (Genetic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... s under development for Achromatopsia, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the thera......" | 30-Apr-2021 | $2000 | |
Gaucher Disease Type I (Genetic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... ormation on the therapeutics under development for Gaucher Disease Type I, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive......" | 30-Apr-2021 | $2000 | |
Inherited Metabolic Disorders (Genetic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... des comprehensive information on the therapeutics under development for Inherited Metabolic Disorders, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report......" | 30-Apr-2021 | $2000 | |
|